S100A1: a promising therapeutic target for heart failure

Dorothea Noll^{1

2}, Dorothea Kehr^{1

2}, Patrick Most^{1

2

3}, Julia Ritterhoff^{1

2}

Affiliations

¹ Molecular and Translational Cardiology, Department of Internal Medicine III, Heidelberg University Hospital, Heidelberg, Germany.
² German Center for Cardiovascular Research (DZHK), Partner Site Heidelberg, Heidelberg, Germany.
³ Center for Translational Medicine, Jefferson University, Philadelphia, PA, USA.

Editorial

Dorothea Noll et al. Expert Opin Ther Targets. 2024 Apr.

. 2024 Apr;28(4):233-236.

doi: 10.1080/14728222.2024.2345746. Epub 2024 Apr 22.

Dorothea Noll^{1

2}, Dorothea Kehr^{1

2}, Patrick Most^{1

2

3}, Julia Ritterhoff^{1

2}

¹ Molecular and Translational Cardiology, Department of Internal Medicine III, Heidelberg University Hospital, Heidelberg, Germany.
² German Center for Cardiovascular Research (DZHK), Partner Site Heidelberg, Heidelberg, Germany.
³ Center for Translational Medicine, Jefferson University, Philadelphia, PA, USA.

No abstract available

Keywords: S100A1; adeno-associated virus; arrhythmias; cell penetrating peptide; gene therapy; inotropy.

Publication types